Expertise in
19
conditions

Vincent Laugel

Strasbourg, FR 
Expertise in
19
conditions
Strasbourg, FR 

Overview

Vincent Laugel practices practicing medicine in Strasbourg, France.

Mr. Laugel is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Cockayne Syndrome Type 1, Cockayne Syndrome, Pena-Shokeir Syndrome Type 2, Cockayne Syndrome Type 2, and Gastrostomy.

He is actively involved in clinical research, co-authoring 111 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Strasbourg, France
Other Locations
Bron, France
Dijon, 21000, France
Tours, France
Rouen, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care
Enrollment Status: Completed
Publish Date: February 24, 2026
Metabolic Study of Cockayne Syndrome
Metabolic Study of Cockayne Syndrome
Enrollment Status: Terminated
Publish Date: August 03, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: August 26, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Tamoxifen in Duchenne Muscular Dystrophy: A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 3 Safety and Efficacy 48-week Trial
Tamoxifen in Duchenne Muscular Dystrophy: A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 3 Safety and Efficacy 48-week Trial
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Drug
Study Drug: Tamoxifen
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)
A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)
Enrollment Status: Terminated
Publish Date: May 20, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

111 Total Publications

Clinical, Histological, and Genetic Characterization of a Large Cohort of 49 Patients With Nebulin-Related Congenital Myopathy.
Clinical, Histological, and Genetic Characterization of a Large Cohort of 49 Patients With Nebulin-Related Congenital Myopathy.
Journal: Human mutation
Published: January 25, 2026

Frequently Asked Questions about Vincent Laugel

Is Vincent Laugel a top-rated expert for Cockayne Syndrome Type 1?

MediFind is an objective health platform that identifies experts based on real-world data. Vincent Laugel is classified as an Elite expert for Cockayne Syndrome Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vincent Laugel participate in research or clinical trials?

Yes. Vincent Laugel has published 111 articles and abstracts on conditions like Cockayne Syndrome Type 1. You can view a list of Vincent Laugel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Laugel's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile